Bioaffinity Technologies Receives Additional $7.7M From Exercise Of Warrants, Total Capital From Public Offering Increases To Approximately $15.6M
Amount Raised
$7.7 Million
Round Type
Post-IPO Equity
San AntonioBiotechnologyHealth CareTherapeuticsHealth DiagnosticsDescription
bioAffinity Technologies, Inc. (NASDAQ: BIAF) (NASDAQ: BIAFW) today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warrants issued in the Company's September 6, 2022, public offering of securities.
Quick answer
bioAffinity Technologies raised $7.7 Million in a Post-IPO Equity round, dated September 28, 2022. bioAffinity Technologies is based in San Antonio, Texas, United States.
- How much did bioAffinity Technologies raise?
- bioAffinity Technologies raised $7.7 Million in a Post-IPO Equity round on September 28, 2022.
- What does bioAffinity Technologies do?
- bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer treatment.
- Where is bioAffinity Technologies based and how big is it?
- bioAffinity Technologies is based in San Antonio, Texas, United States. Fundz records about 34 employees.
- Who are the decision-makers at bioAffinity Technologies?
- Fundz holds 2 contacts at bioAffinity Technologies, including the Vice President, US Sales. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Health Diagnostics around the same time
Companies in the same sectors as bioAffinity Technologies that raised within 45 days of this round, from Fundz verified event records.
- Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
- Kinimmune raised an undisclosed amount (Funding Round) on November 9, 2022.
- NRG Therapeutics raised $18M (Series A) on November 9, 2022.
- Ibex Medical Analytics raised $10M (Funding Round) on November 9, 2022.
- Secure AI Labs raised $4.7M (Seed) on November 8, 2022.
- Osler Diagnostics raised $85M (Funding Round) on November 8, 2022.
Who to call at bioAffinity Technologies, and when
A new round usually means bioAffinity Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day bioAffinity Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at bioAffinity Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at bioAffinity Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment bioAffinity Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
bioAffinity Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.